Journal of the Renin-Angiotensin-Aldosterone System最新文献_第10页

Treatment of Essential Hypertension with Emphasis in the Renin-Angiotensin System: How to Prevent Secondary Outcomes without Adding Fuel to the Fire 以肾素-血管紧张素系统为重点治疗原发性高血压:如何在不火上浇油的情况下预防继发性结局

IF 2.9 4区医学

Journal of the Renin-Angiotensin-Aldosterone System Pub Date : 2019-07-18 DOI: 10.5772/INTECHOPEN.86853

G. L. Salvador

引用次数: 0

From Angiotensin to Renin to Prorenin and from the Adrenal to the Kidney to the Placenta and the Lungs: An Historical Journey 从血管紧张素到肾素再到原肾素，从肾上腺到肾脏再到胎盘和肺:一个历史的旅程

IF 2.9 4区医学

Journal of the Renin-Angiotensin-Aldosterone System Pub Date : 2019-07-17 DOI: 10.5772/INTECHOPEN.87041

A. Poisner

{"title":"From Angiotensin to Renin to Prorenin and from the Adrenal to the Kidney to the Placenta and the Lungs: An Historical Journey","authors":"A. Poisner","doi":"10.5772/INTECHOPEN.87041","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.87041","url":null,"abstract":"In 1966 I carried out a study on the role of calcium on angiotensin’s stimulant effects on the adrenal medulla. Since then I have been studying the renin-angiotensin system (RAS) for over a half-century in a wide variety of biological preparations, while awareness of its complexity has exploded. My journey has involved studies on genes, proteins, organelles, cells, tissues, glands, organs and whole animals. This chapter reviews what my colleagues and I have learned from these different levels of organization and is not meant to be an update on all features of the RAS. My studies have included experiments on: perfused cat adrenal glands; genetic and second messenger control of catecholamine synthesis and secretion from cultured bovine chromaffin cells and from rats in vivo; renin storage and release in the rat kidney and secretory granules; properties of isolated renin, prorenin and renin-like proteins; hormonal and second messenger control of prorenin secretion from human utero-placental tissues; renin/prorenin in a variety of tumors; and the effect of RAS drugs in a rodent model of pulmonary fat embolism. This most recent study has direct clinical application. I conclude with what I have learned about biomedical research and lessons for the future.","PeriodicalId":17330,"journal":{"name":"Journal of the Renin-Angiotensin-Aldosterone System","volume":"91 1","pages":""},"PeriodicalIF":2.9,"publicationDate":"2019-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75787830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Effects of telmisartan and losartan treatments on bone turnover markers in patients with newly diagnosed stage I hypertension 替米沙坦和氯沙坦治疗对新诊断I期高血压患者骨转换标志物的影响

IF 2.9 4区医学

Journal of the Renin-Angiotensin-Aldosterone System Pub Date : 2019-07-01 DOI: 10.1177/1470320319862741

B. I. Aydoğan, Emrah Erarslan, U. Ünlütürk, S. Güllü

{"title":"Effects of telmisartan and losartan treatments on bone turnover markers in patients with newly diagnosed stage I hypertension","authors":"B. I. Aydoğan, Emrah Erarslan, U. Ünlütürk, S. Güllü","doi":"10.1177/1470320319862741","DOIUrl":"https://doi.org/10.1177/1470320319862741","url":null,"abstract":"Introduction: Telmisartan is an angiotensin-II receptor type-1 blocker and a partial agonist for peroxisome proliferator-activated receptor-γ. The aim of this study was to determine the potential effects of telmisartan on bone metabolism and turnover markers. Methods: Forty-two patients with newly diagnosed stage I hypertension who were prescribed telmisartan 80 mg/day or losartan 100 mg/day were included. Serum levels of calcium, phosphorus, 25-hydroxy vitamin D, bone-specific alkaline phosphatase, osteocalcin, interleukin 6 and 24-hour urinary N-terminal telopeptide were measured at the beginning and after 12 weeks of treatment. Results: When treatment arms were evaluated together, significantly increased 25-hydroxy vitamin D levels (p=0.01), and decreased parathormone (PTH) (p<0.001), bone-specific alkaline phosphatase (p=0.01), osteocalcin (p=0.045), urinary N-terminal telopeptide (p<0.001) and interleukin 6 levels (p=0.006) were observed. After eliminating the 25-hydroxy vitamin D effect, significant changes were not observed at any of the parameters. None of the levels of parameters were different between groups. Conclusions: Neither telmisartan, despite its partial peroxisome proliferator-activated receptor-γ agonistic effect, nor losartan treatment had significant effects on bone turnover markers in newly diagnosed stage I hypertensive patients.","PeriodicalId":17330,"journal":{"name":"Journal of the Renin-Angiotensin-Aldosterone System","volume":"52 1","pages":""},"PeriodicalIF":2.9,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90127536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 6

Effects of combined statin and ACE inhibitor therapy on endothelial function and blood pressure in essential hypertension - a randomised double-blind, placebo controlled crossover study 他汀类药物联合ACE抑制剂治疗对原发性高血压患者内皮功能和血压的影响——一项随机、双盲、安慰剂对照交叉研究

IF 2.9 4区医学

Journal of the Renin-Angiotensin-Aldosterone System Pub Date : 2019-07-01 DOI: 10.1177/1470320319868890

P. Ruszkowski, Anna Masajtis-Zagajewska, M. Nowicki

{"title":"Effects of combined statin and ACE inhibitor therapy on endothelial function and blood pressure in essential hypertension - a randomised double-blind, placebo controlled crossover study","authors":"P. Ruszkowski, Anna Masajtis-Zagajewska, M. Nowicki","doi":"10.1177/1470320319868890","DOIUrl":"https://doi.org/10.1177/1470320319868890","url":null,"abstract":"Background: The aim of this study was to compare the influence of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on endothelial function and blood pressure in patients with essential hypertension on long-term angiotensin-converting enzyme inhibitor therapy. Method: The study was designed as a prospective, double-blind, randomised, placebo controlled, crossover clinical trial. Twenty patients with essential hypertension were treated with an angiotensin-converting enzyme inhibitor; the control group included 10 healthy subjects. Hypertensive patients received in random order 80 mg of fluvastatin daily or placebo for 6 weeks. The following parameters were assessed at baseline and after each treatment period: serum lipids, flow-mediated vasodilation, activity of von Willebrand factor, concentration of vascular endothelial growth factor, C-reactive protein and 24-hour blood pressure profile. Results: Hypertensive patients did not differ from healthy subjects with respect to age, body mass and biochemical parameters, with the exception of C-reactive protein, which was higher in hypertensive patients (P=0.02). After statin therapy, low-density lipoprotein cholesterol (P<0.0001), C-reactive protein (P=0.03), von Willebrand factor (P=0.03) and vascular endothelial growth factor (P<0.01) decreased and flow-mediated vasodilation improved (P<0.001). Statins had no significant effect on blood pressure. Conclusions: Statins added to angiotensin-converting enzyme inhibitors may improve endothelial function and ameliorate inflammation independently of blood pressure.","PeriodicalId":17330,"journal":{"name":"Journal of the Renin-Angiotensin-Aldosterone System","volume":"13 1","pages":""},"PeriodicalIF":2.9,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88321244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 15

No effect of the angiotensin receptor blocker candesartan on cerebrovascular autoregulation in rats during very high and low sodium intake. 血管紧张素受体阻滞剂坎地沙坦对高钠和低钠大鼠脑血管自动调节无影响。

IF 2.9 4区医学

Journal of the Renin-Angiotensin-Aldosterone System Pub Date : 2019-07-01 DOI: 10.1177/1470320319874615

Sigurdur T Sigurdsson, Peter Bie, Arne H Nielsen, Svend Strandgaard, Olaf B Paulson

{"title":"No effect of the angiotensin receptor blocker candesartan on cerebrovascular autoregulation in rats during very high and low sodium intake.","authors":"Sigurdur T Sigurdsson, Peter Bie, Arne H Nielsen, Svend Strandgaard, Olaf B Paulson","doi":"10.1177/1470320319874615","DOIUrl":"https://doi.org/10.1177/1470320319874615","url":null,"abstract":"Autoregulation of cerebral blood flow (CBF) denotes that CBF is constant despite fluctuation of blood pressure within wide limits. Inhibition of the renin-angiotensin system (RAS) is known to decrease the lower and upper limits of CBF autoregulation. We have previously shown that this includes inhibition by the angiotensin receptor blocker (ARB) candesartan. In the present study we investigated the influence of the ARB candesartan on the lower limit of CBF autoregulation in two groups of Sprague-Dawley rats, on high (4.0% Na+) and low (0.004% Na+) sodium diet, respectively. Control animals were given the same diet, but no ARB. CBF was studied with the laser Doppler method. Blood pressure was lowered by controlled bleeding. Results revealed that both high and low sodium diet with low and high renin levels respectively block the influence of candesartan on CBF autoregulation. This was expected in rats on a high salt diet with a low renin level, but unexpected in rats with a low salt intake with a high renin level.","PeriodicalId":17330,"journal":{"name":"Journal of the Renin-Angiotensin-Aldosterone System","volume":"20 3","pages":"1470320319874615"},"PeriodicalIF":2.9,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1470320319874615","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37723682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The characteristics of captopril challenge test–positive patients using various criteria 卡托普利挑战试验阳性患者的特点

IF 2.9 4区医学

Journal of the Renin-Angiotensin-Aldosterone System Pub Date : 2019-07-01 DOI: 10.1177/1470320319870891

Satoshi Kidoguchi, Naoki Sugano, Naomi Hayashi-Ishikawa, Norihiko Morisawa, Goro Tokudome, T. Yokoo

{"title":"The characteristics of captopril challenge test–positive patients using various criteria","authors":"Satoshi Kidoguchi, Naoki Sugano, Naomi Hayashi-Ishikawa, Norihiko Morisawa, Goro Tokudome, T. Yokoo","doi":"10.1177/1470320319870891","DOIUrl":"https://doi.org/10.1177/1470320319870891","url":null,"abstract":"Introduction: The captopril challenge test (CCT) is the major confirmatory test for primary aldosteronism (PA), and frequently carried out because of its convenience. However, it presents false-negative results with a certain probability, and as there are many criteria for CCT, it is not concluded yet which criteria to use. Materials and methods: A total of 71 PA patients were evaluated. We compared CCT-positive and CCT-negative patients in the following three criteria: plasma aldosterone/renin ratio (ARR) >200 after the CCT (criterion 1); plasma aldosterone concentration (PAC) >120 pg/ml after the CCT (criterion 2); and PAC suppression <30% of PAC before CCT (criterion 3). Results: The positive rate was 70.4%, 64.8% and 54.9% for criterion 1, criterion 2 and criterion 3, respectively. With criterion 1, the baseline plasma renin activity was lower, thus baseline ARR was higher in CCT-positive patients. With criterion 2, PAC was higher and estimated sodium intake and K were lower in CCT-positive patients. With criterion 3, K and PAC were lower in CCT-positive patients. Although it was not significant, in the patients with high sodium intake, the positive rate of criterion 1 was higher than that of the other criteria. Conclusions: ARR>200 is the valuable criterion for the diagnosis of PA.","PeriodicalId":17330,"journal":{"name":"Journal of the Renin-Angiotensin-Aldosterone System","volume":"12 1","pages":""},"PeriodicalIF":2.9,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77754865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

ACE insertion/deletion genetic polymorphism, serum ACE levels and high dietary salt intake influence the risk of obesity development among the Saudi adult population ACE插入/缺失基因多态性、血清ACE水平和高饮食盐摄入量影响沙特成年人群肥胖发展的风险

IF 2.9 4区医学

Journal of the Renin-Angiotensin-Aldosterone System Pub Date : 2019-07-01 DOI: 10.1177/1470320319870945

J. Sabir, A. Omri, Imran Ali Khan, B. Banaganapalli, N. Hajrah, Houda Zrelli, A. M. Omar, M. Alharbi, Alawiah M. Alhebshi, R. Jansen, A. Altaf, N. Shaik, Muhummadh Khan

{"title":"ACE insertion/deletion genetic polymorphism, serum ACE levels and high dietary salt intake influence the risk of obesity development among the Saudi adult population","authors":"J. Sabir, A. Omri, Imran Ali Khan, B. Banaganapalli, N. Hajrah, Houda Zrelli, A. M. Omar, M. Alharbi, Alawiah M. Alhebshi, R. Jansen, A. Altaf, N. Shaik, Muhummadh Khan","doi":"10.1177/1470320319870945","DOIUrl":"https://doi.org/10.1177/1470320319870945","url":null,"abstract":"Introduction: Angiotensin-converting enzyme (ACE), which contributes to adipocyte growth, differentiation and function, has recently been linked with both salt metabolism and obesity development. Therefore, this study has aimed to investigate the putative relationship between ACE genetic polymorphism, serum ACE levels and salt consumption on the risk of developing obesity in the Saudi population. Materials and methods: ACE genotype status of 267 adult Saudi volunteers (124 obese and 143 non-obese) was correlated with their serum ACE activity and dietary salt intake amounts. Results: Obesity was more prevalent in deletion-deletion genotype individuals (p<0.03), under dominant, co-dominant and monoallelic conditions (p<0.04). Deletion allele corresponds to serum ACE activity in obese patients (p<0.05). The amount of salt intake (<6 g/d) was significantly associated with obesity and particularly high in deletion-deletion and insertion-deletion genotype carriers (p<0.001). STITCH analysis underlined interactions of the ACE protein with sodium molecule, REN, ACE2, KNG1 and AGTR1 in a biological network. Conclusions: Our findings suggest the positive association between ACE deletion genotype, serum ACE activity and sodium intake with risk of obesity development in the Saudi population.","PeriodicalId":17330,"journal":{"name":"Journal of the Renin-Angiotensin-Aldosterone System","volume":"281 1","pages":""},"PeriodicalIF":2.9,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76793625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 9

Connexin-Based Channels and RhoA/ROCK Pathway in Angiotensin II-Induced Kidney Damage 基于连接蛋白的通道和RhoA/ROCK通路在血管紧张素ii诱导的肾损伤中

IF 2.9 4区医学

Journal of the Renin-Angiotensin-Aldosterone System Pub Date : 2019-06-22 DOI: 10.5772/INTECHOPEN.87040

G. Gómez, V. Velarde, J. Sáez

{"title":"Connexin-Based Channels and RhoA/ROCK Pathway in Angiotensin II-Induced Kidney Damage","authors":"G. Gómez, V. Velarde, J. Sáez","doi":"10.5772/INTECHOPEN.87040","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.87040","url":null,"abstract":"The incidence of chronic kidney diseases is increasing worldwide, and there is no efficient therapy to reduce this phenomenon. The main therapies currently available focus on the control of blood pressure and the optimization of the blockade of the renin-angiotensin system (RAS). In addition, it is known that in several models of kidney damage, the amounts of connexins are altered. On the other hand, fasudil, a selective ROCK blocker, has shown renoprotective effects. The beneficial effects of blocking the RhoA/ROCK pathway in renal function may be related to its action of reducing macrophage infiltration, inflammation, and oxidative stress (OS), its expression of extracellular matrix genes and proteinuria, or to its effects on connexin abundance. Even though a correlation has been found between renal damage, caused by an increase in the RAS activity, connexins, and the RhoA/ROCK signaling pathway, it has not yet been possible to clearly determine its functional significance. Moreover, it has not been possible to identify the preponderance of this signaling pathway in the development of chronic kidney diseases. Here, we describe the advances in this subject.","PeriodicalId":17330,"journal":{"name":"Journal of the Renin-Angiotensin-Aldosterone System","volume":"22 1","pages":""},"PeriodicalIF":2.9,"publicationDate":"2019-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83738639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

The impact of At1r inhibition via losartan on the anti-leukaemic effects of doxorubicin in acute myeloid leukaemia. 氯沙坦抑制At1r对阿霉素治疗急性髓性白血病抗白血病作用的影响。

IF 2.9 4区医学

Journal of the Renin-Angiotensin-Aldosterone System Pub Date : 2019-04-01 DOI: 10.1177/1470320319851310

Mehdi Ghasemi, Mufide Okay, Seyhan Turk, Ronak Naeemaee, Ebru Guver, Umit Y Malkan, Salih Aksu, Nilgun Sayinalp, Ibrahim C Haznedaroglu

{"title":"The impact of At1r inhibition via losartan on the anti-leukaemic effects of doxorubicin in acute myeloid leukaemia.","authors":"Mehdi Ghasemi, Mufide Okay, Seyhan Turk, Ronak Naeemaee, Ebru Guver, Umit Y Malkan, Salih Aksu, Nilgun Sayinalp, Ibrahim C Haznedaroglu","doi":"10.1177/1470320319851310","DOIUrl":"https://doi.org/10.1177/1470320319851310","url":null,"abstract":"Introduction: Bone marrow renin-angiotensin system(RAS) modulates acute myeloid leukaemia(AML).The aim of this study is to clarify the relationships between RAS and AML, and to show the effect of losartan and doxorubicin treatment in AML cell lines.Methods: AML cell lines including CESS, HL-60, MO-1, P31/FUJ, GDM-1 and KASUMI-3 were used as models in this study.Results: After treating the six AML cell lines with a combination of losartan and doxorubicin, they were divided into two groups based on their behaviour: one became more sensitive to drug treatment (Group A) and the other had no change observed in behaviour after drug treatment (Group B). In silico analyses showed that Group A is involved in cellular apoptosis, while Group B is involved in tumour angiogenesis further supporting the in vitro results.Conclusion: The combined treatment of the AML cell lines with losartan and doxorubicin resulted in an increase in sensitivity of some of the cell lines. Those leukaemic cells are modulated via the induction of apoptosis, whereas the other cells resistant to the drug treatment are closely related to tumour angiogenesis indicating that RAS-AT1R seems to be differently expressed in different leukaemic blast cells and tumour microenvironments. Pharmaco-biological actions of RAS inhibitors may be different in distinct leukaemic cells based on the pathological behaviour of AML genomic subtypes.","PeriodicalId":17330,"journal":{"name":"Journal of the Renin-Angiotensin-Aldosterone System","volume":"20 2","pages":"1470320319851310"},"PeriodicalIF":2.9,"publicationDate":"2019-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1470320319851310","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37264528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 5

Reviewers list 审阅人员列表

IF 2.9 4区医学

Journal of the Renin-Angiotensin-Aldosterone System Pub Date : 2019-01-01 DOI: 10.1177/1470320319831142

{"title":"Reviewers list","authors":"","doi":"10.1177/1470320319831142","DOIUrl":"https://doi.org/10.1177/1470320319831142","url":null,"abstract":"Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). Adaya, Ceyla Aguilar, Marie-Isabel Allen, Terri Almeida, Madison Arumugam, Vijaya Barbosa da Silva, Sandra Barwood, Martin Bernardi, Stella Borghi, Claudio Bourgi, Ali Braszko, Jan Canto, Patricia Capewell, Simon Capuccio, Franco Cardillo, Carmine Carlsson, AC Chappell, Mark Danilov, Sergei Delevatti, RS der Groot, Joris Du, Jun-Bao Ekholm, Mikael Erbas, Tomris Ferrario, Carlos Fonseca-Alaniz, MH Fuller, Peter Funder, John Gismondi, Ronaldo Goessler, Karla Gregg, Lucile Gromotowicz-Poplawska, Anna Gros, Robert Hayashi, Kaori Hering, Dagmara Hevia, Vital Ho, Jean Holtzenberg, Maria ISORDIA-SALAS, IRMA Jalil, Jorge Jin, Hongfang Kamei, Motohiro Kosar, Ali Kurlak, Lesi Li, Qifu Liu, Fang-zhou Liu, L Lu, Xifeng MacGregor, Graham Miak, Radoslaw Mohan, Irwin Moraes, Karen Morimoto, Satoshi Murakami, T Narayan, Prakash Ohashi, N Omboni, Stefano Rodriguez, R Roks, Anton Rossi, Gianpaolo Rubio Guerra, Alberto Francisco Säemann, Marcus Saigusa, T Sever, Peter Sharifi, Niura Shenoy, Vinayak Shu, Daisy Siltari, Aino Simao, S Simoes e Silva, Ana Simone, Giuseppe Simonyte, Sandrita Simonyte, Sandrita Song, Ping Stegbauer, Johannes Tain, You-Lin White, Andrew Woo, KT Xue, B Zhao, Qinchum Zhu, Mei Reviewers list","PeriodicalId":17330,"journal":{"name":"Journal of the Renin-Angiotensin-Aldosterone System","volume":"107 1","pages":""},"PeriodicalIF":2.9,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83552127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0